Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability
Lizhou Zhang, Kunal R. More, Amrita Ojha, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Effects of nanoparticle size, shape, and zeta potential on drug delivery
Kıvılcım Öztürk, Meryem Kaplan, Sema Çalış
International Journal of Pharmaceutics (2024), pp. 124799-124799
Closed Access | Times Cited: 40
Rational design and modular synthesis of biodegradable ionizable lipids via the Passerini reaction for mRNA delivery
Yue Xu, Fanglin Gong, Alex Golubovic, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 5
Open Access | Times Cited: 2
Nucleic acid drugs: recent progress and future perspectives
Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework
S Kavikondala, Katrin Haeussler, Xuan Wang, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 4, pp. 779-811
Open Access | Times Cited: 11
Advances in the design and delivery of RNA vaccines for infectious diseases
Abhijeet Lokras, Thomas Rønnemoes Bobak, Saahil Baghel, et al.
Advanced Drug Delivery Reviews (2024) Vol. 213, pp. 115419-115419
Open Access | Times Cited: 11
The mRNA vaccine, a swift warhead against a moving infectious disease target
Sheema Mir, Mohammad A. Mir
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 336-348
Open Access | Times Cited: 9
pH‐Responsive β‐Glucans‐Complexed mRNA in LNPs as an Oral Vaccine for Enhancing Cancer Immunotherapy
Po‐Kai Luo, Hui‐Min Ho, Min‐Chun Chiang, et al.
Advanced Materials (2024) Vol. 36, Iss. 33
Closed Access | Times Cited: 9
S6P mutation in Delta and Omicron variant spike protein significantly enhances the efficacy of mRNA COVID-19 vaccines
Yong‐Sik Bong, David Alan Brown, Ezra Chung, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
mRNA‐laden lipid nanoparticle‐enabled humanized CD19 CAR‐T‐cell engineering for the eradication of leukaemic cells
Zhaozhao Chen, Anqi Ren, Yingying Li, et al.
British Journal of Haematology (2025) Vol. 206, Iss. 2, pp. 628-643
Open Access | Times Cited: 1
Enhanced stability and efficacy of a lyophilized mRNA SARS-CoV-2 vaccine incorporating novel Ionizable lipids after one year storage at 25ºC
Elena Mata, Esther Broset, Carlos Matute, et al.
Research Square (Research Square) (2025)
Closed Access | Times Cited: 1
Advances in nucleic acid-based cancer vaccines
Hung‐Chun Liao, Shih‐Jen Liu
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 1
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Adults with Underlying Medical Conditions: Systematic Literature Review and Pairwise Meta-Analysis Using GRADE
Xuan Wang, Ankit Pahwa, Mary T. Bausch-Jurken, et al.
Advances in Therapy (2025)
Open Access | Times Cited: 1
mRNA lipid nanoparticle formulation, characterization and evaluation
Yutian Ma, Rachel VanKeulen-Miller, Owen S. Fenton
Nature Protocols (2025)
Closed Access | Times Cited: 1
Marginal-zone B cells as promising targets of an mRNA-loaded, lipid-nanoparticle cancer vaccine
Yuichi Suzuki, Mai Yakuwa, Mina Sato, et al.
Next Nanotechnology (2025) Vol. 8, pp. 100154-100154
Open Access | Times Cited: 1
Enhancing vaccine stability in transdermal microneedle platforms
Suman Pahal, Feifei Huang, Parbeen Singh, et al.
Drug Delivery and Translational Research (2025)
Closed Access | Times Cited: 1
The potential of mRNA vaccines in cancer nanomedicine and immunotherapy
Shulin Pan, Rangrang Fan, Bo Han, et al.
Trends in Immunology (2023) Vol. 45, Iss. 1, pp. 20-31
Closed Access | Times Cited: 20
Advances in lipid nanoparticle mRNA therapeutics beyond COVID-19 vaccines
Yeung Wu, Sinuo Yu, Irene de Lázaro
Nanoscale (2024) Vol. 16, Iss. 14, pp. 6820-6836
Closed Access | Times Cited: 8
Advances in nucleic acid-targeted therapies for cardiovascular disease prevention
Umidakhon Makhmudova, Elisabeth Steinhagen‐Thiessen, Massimo Volpe, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 10, pp. 1107-1125
Open Access | Times Cited: 7
mRNA compartmentalization via multimodule DNA nanostructure assembly augments the immunogenicity and efficacy of cancer mRNA vaccine
Xiaocui Guo, Mengyu Guo, Rong Cai, et al.
Science Advances (2024) Vol. 10, Iss. 47
Open Access | Times Cited: 7
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
Laura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Immunogenicity and effectiveness of an mRNA therapeutic vaccine for HPV-related malignancies
Jing Wang, Ling Ma, Yunfeng Chen, et al.
Life Science Alliance (2024) Vol. 7, Iss. 6, pp. e202302448-e202302448
Open Access | Times Cited: 6
Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA delivery
Md. Anamul Haque, Archana Shrestha, Constantinos M. Mikelis, et al.
International Journal of Pharmaceutics X (2024) Vol. 8, pp. 100283-100283
Open Access | Times Cited: 6
Tailoring lipid nanoparticle dimensions through manufacturing processes
Caitlin McMillan, Amy Druschitz, Stephen Rumbelow, et al.
RSC Pharmaceutics (2024)
Open Access | Times Cited: 6
Zwitterionic materials for nucleic acid delivery and therapeutic applications
Shun He, Shuai Liu
Journal of Controlled Release (2023) Vol. 365, pp. 919-935
Closed Access | Times Cited: 16
Incorporation of poly(γ-glutamic acid) in lipid nanoparticles for enhanced mRNA delivery efficiency in vitro and in vivo
Hongqian Zhang, Xue Gao, Qian Sun, et al.
Acta Biomaterialia (2024) Vol. 177, pp. 361-376
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top